The optimal duration of adjuvant tamoxifen treatment for breast cancer remains uncertain: randomize into aTTom.
Earl
H
H
Gray
R
R
Kerr
D
D
Lee
M
M
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D012107:Research Design; D013629:Tamoxifen / Q000627:therapeutic use*; D013997:Time Factors
D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen